Radical Deoxychlorination of Cesium Oxalates for the Synthesis of Alkyl Chlorides

Scientific Literature

Abstract

A radical deoxychlorination of cesium oxalates has been developed for the preparation of hindered secondary and tertiary alkyl chlorides. The reaction tolerates a number of functional groups, including ketones, alcohols, and amides, and provides complementary reactivity to standard deoxychlorination reactions proceeding by heterolytic mechanisms. Preliminary studies demonstrate that the developed conditions can also be applied to deoxybromination and deoxyfluorination reactions.

Authors: Justin Y. Su, Denise C. Grünenfelder, Kohei Takeuchi, Sarah E. Reisman*

Link: https://pubs.acs.org/doi/10.1021/acs.orglett.8b02045

Photochemistry

Hepatochem offers a variety of photochemistry reactors and accessories that are used throughout the world to explore chemical conditions. All of our reactors are compatible with most vial formats and stirring plates. We also offer several photochemistry screening kits for calibration and accuracy.

Contact Us!

Interested in learning more about our products?
Complete our short contact form and we'll get back to you as soon as possible.

Photochemistry Starter Bundle

Our Photochemistry Starter Bundle includes everything you need to further explore the opportunities inherent with photochemical reactions. The Starter Bundle includes our standard photoreactor, two LED light sources, two vial holders, four sample reactions and UV safety glasses.

The Biomimetic Advantage

While microsomes have proven valuable as a predictive tool, their productive capabilities are limited. Biomimetic Chemistry, on the other hand, possesses the advantages of both chemistry and biology and is thus a much more efficient tool for metabolite synthesis.

See our Side By Side Comparison Chart Here

Metabolite Synthesis

Through our revolutionary technology, HepatoChem enables cost effective testable quantities of metabolites in-house even at the earliest stages of drug discovery. This new capability, which enables affordable early metabolite toxicity testing, offers drug companies the opportunity to save millions each year through dramatically improved drug pipelines.